Rejected at 2:14 p.m. Jun, 29, 2025 ] by Ahmed7
Author: dyoonars
Related Note: 1473995480416 1
Rationale for change

Typo in 4e883e3de5e8e5078c08fdd991823e2a.webp

Instrinic → Intrinsic

Rejection reason

fixed now, thank you

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step1_v12::#AMBOSS::f-0k9i #AK_Step1_v12::#UWorld::Step::1291 #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::02_Bleeding_Time,_Prothrombin_Time,_INR,_and_Partial_Thromboplastin_Time #AK_Step1_v12::#SketchyPhysiology::10_Hematology::01_Blood_Components_&_Function::01_Coagulation_Cascade #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::01_Coagulation_Cascade #AK_Step2_v12::#UWorld::Step::115473 #AK_Step1_v12::#Pixorize::01_Biochemistry::17_Coagulation::02_Extrinsic_Pathway_of_Coagulation #AK_Other::!AK_UpdateTags::AnKing_Image::Aiman #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::02_Coagulopathy #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Hematology::Coagulation_Cascade #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::01_Coagulation #AK_Other::!AK_UpdateTags::AnKing_Image::Aiman::Coagulation_Cascade #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::16_Coagulation_disorders #AK_Step1_v12::#Pixorize::01_Biochemistry::21_Lab_Diagrams::03_Coagulation_Panel #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step1_v12::#UWorld::COMLEX::24402 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#AMBOSS::RC0l7R #AK_Step1_v12::#UWorld::COMLEX::27361 #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::04_Coagulopathies::Extra #AK_Step1_v12::#Pixorize::01_Biochemistry::17_Coagulation::04_Hemophilia_A #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Step1_v12::#UWorld::Step::20361 #PANCE::HEME::coagulation_disorders #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::02_Secondary_Hemostasis #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::03_Physiology::05_Coagulation_and_kinin_pathways::*Coagulation_Cascade #AK_Step1_v12::^Systems::HemeOnc::Hematology #AK_Step1_v12::#Pathoma::04_Hemostasis::02_Secondary_Hemostasis_&_Related_Disorders